Literature DB >> 18820360

Incidence of Haemophilus influenzae type b meningitis in India.

S Minz1, V Balraj, M K Lalitha, N Murali, T Cherian, G Manoharan, S Kadirvan, A Joseph, M C Steinhoff.   

Abstract

BACKGROUND &
OBJECTIVE: Vaccine policy depends on locally relevant disease burden estimates. The incidence of Haemophilus influenzae type b (Hib) disease is not well characterized in the South Asian region, home to 30 per cent of the world's children. There are limited data from prospective population incidence studies of Hib in Asia, and no data available from India. We therefore carried out this study to assess the burden of Hib meningitis in India.
METHODS: A prospective surveillance study was carried out during 1997 and 1999 in hospitals for cases of Hib meningitis from 5 administrative areas of an Indian district (Vellore, Tamil Nadu) with 56,153 children under 5 yr of age, over a 24 month period
RESULTS: Ninety seven cases of possible meningitis (> 10 WBC/microl in CSF) were reported, an annual incidence of 86 per 100,000 (95%CI 69 to 109) in 0-4 yr old children, and 357 per 100,000 in 0-11 month infants. Eighteen had proven bacterial meningitis, an annual incidence of 15.9 per 100,000. Eight CSF had Hib by culture or antigen testing, an annual incidence of 7.1 per 100,000 (95%CI 3.1 to 14.0) in children 0-59 months. In infants 0-11 months of age, the incidence of Hib meningitis was 32 per 100,000 (95%CI 16 to 67) and in the 0-23 month group it was 19 (95%CI 8 to 37). INTERPRETATION &
CONCLUSION: Our data are the first minimal estimate of the incidence of Hib meningitis for Indian children. The observed incidence data are similar to European reports before Hib vaccine use, suggest substantial disease before 24 months of age, and provide data useful for policy regarding Hib immunization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820360

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  15 in total

1.  Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.

Authors:  Ulla Kou Griffiths; Andrew Clark; Rana Hajjeh
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

2.  Pentavalent vaccine: a major breakthrough in India's Universal Immunization Program.

Authors:  Mohan Bairwa; Manju Pilania; Meena Rajput; Pardeep Khanna; Neelam Kumar; Mukesh Nagar; Sumit Chawla
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Pentavalent vaccine and adverse events following immunization-untangling the misinterpretations.

Authors:  Akash Malik
Journal:  Indian J Pediatr       Date:  2014-02-07       Impact factor: 1.967

4.  Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.

Authors:  Andrew D Clark; Ulla K Griffiths; Syed Shahid Abbas; Krishna D Rao; Lois Privor-Dumm; Rana Hajjeh; Hope Johnson; Colin Sanderson; Mathuram Santosham
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

5.  Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007-2008.

Authors:  Kathleen F Cavallaro; Hardeep S Sandhu; Terri B Hyde; Barbara W Johnson; Marc Fischer; Leonard W Mayer; Thomas A Clark; Mark A Pallansch; Zundong Yin; Shuyan Zuo; Stephen C Hadler; Serguey Diorditsa; A S M Mainul Hasan; Anindya S Bose; Vance Dietz
Journal:  Vaccine       Date:  2015-01-15       Impact factor: 3.641

6.  Introducing pentavalent vaccine in EPI in India: a counsel for prudence in interpreting scientific literature.

Authors:  Madhu Gupta; Shankar Prinja; Dinesh Kumar; Rajesh Kumar
Journal:  Indian J Med Res       Date:  2011-05       Impact factor: 2.375

7.  "To use or not to use"- dilemma of developing countries in introducing new vaccines.

Authors:  Giridhara R Babu; Gvs Murthy
Journal:  J Glob Infect Dis       Date:  2011-10

8.  Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry.

Authors:  Maria Karanika; Vasiliki A Vasilopoulou; Antonios T Katsioulis; Panagiotis Papastergiou; Maria N Theodoridou; Christos S Hadjichristodoulou
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

9.  A roller-coaster ride: Introduction of pentavalent vaccine in India.

Authors:  Harish Nair; Indrajit Hazarika; Ashok Patwari
Journal:  J Glob Health       Date:  2011-06       Impact factor: 4.413

10.  Prospective multi-centre sentinel surveillance for Haemophilus influenzae type b & other bacterial meningitis in Indian children.

Authors:  Padmanabhan Ramachandran; Sean Patrick Fitzwater; Satinder Aneja; Valsan Philip Verghese; Vishwajeet Kumar; Krishnamoorthy Nedunchelian; Nitya Wadhwa; Balaji Veeraraghavan; Rashmi Kumar; Mohamed Meeran; Arti Kapil; Sudha Jasmine; Aarti Kumar; Saradha Suresh; Shinjini Bhatnagar; Kurien Thomas; Shally Awasthi; Mathuram Santosham; Aruna Chandran
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.